Rollins, Inc.
34.54USD
-0.4100 (-1.17%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.35▼ | $0.39 | 0 | 13 |
| Next quarter | $0.27▼ | $0.28 | 1 | 12 |
| Current year | $1.17▼ | $1.25 | 0 | 2 |
| Next year | $1.3▼ | $1.4 | 0 | 17 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.34 | $0.32 | -0.02 (-5.8%) |
| 2026-03-31 | $0.24 | $0.24 | +0.00 (+1.3%) |
| 2025-12-31 | $0.27 | $0.25 | -0.02 (-6.6%) |
| 2025-09-30 | $0.33 | $0.35 | +0.02 (+6.4%) |
96 ratings from 23 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Argus Research | Downgraded from Buy | Hold | — | Aug 5, 2026 |
| UBS | Maintained | Neutral | $50 $43 | Jul 25, 2026 |
| Canaccord Genuity | Maintained | Hold | $51 $45 | Jul 25, 2026 |
| BNP Paribas | Maintained | Neutral | $63 $44 | Jul 24, 2026 |
| Barclays | Maintained | Overweight | $72 $45 | Jul 24, 2026 |
| Piper Sandler | Maintained | Overweight | $72 $46 | Jul 24, 2026 |
| Wells Fargo | Downgraded from Equal-Weight | Underweight | $46 $32 | Jul 24, 2026 |
| JP Morgan | Downgraded from Overweight | Neutral | $70 $45 | Jul 24, 2026 |
| RBC Capital | Downgraded from Outperform | Sector Perform | $52 $40 | Jul 23, 2026 |
| B of A Securities | Downgraded from Buy | Underperform | $55 $35 | Jul 23, 2026 |
| Citigroup | Initiated | Neutral | $46 | Jul 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $70 $65 | Jul 8, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $55 $46 | Jun 25, 2026 |
| Bernstein | Downgraded from Outperform | Market Perform | $70 $52 | May 29, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $58 $55 | May 15, 2026 |
| UBS | Maintained | Neutral | $58 $61 | Apr 24, 2026 |
| Canaccord Genuity | Maintained | Hold | $52 $51 | Apr 24, 2026 |
| Loop Capital | Initiated | Hold | $56 | Apr 13, 2026 |
| UBS | Maintained | Neutral | $62 $58 | Apr 10, 2026 |
| Canaccord Genuity | Maintained | Hold | $55 $52 | Feb 13, 2026 |
| RBC Capital | Maintained | Outperform | $70 $67 | Feb 12, 2026 |
| Wells Fargo | Downgraded from Overweight | Equal-Weight | $68 $56 | Feb 12, 2026 |
| UBS | Maintained | Neutral | $61 $65 | Jan 21, 2026 |
| Wells Fargo | Maintained | Overweight | $65 $68 | Jan 14, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $58 $72 | Dec 17, 2025 |
82 filings from 22 insiders · 0 buy / 0 sell over 6m
Officers and directors of ROL, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| WILSON JOHN FOfficer and Director | Gift | 87.0k | — | — | Aug 25, 2026 |
| HARKINS WILLIAM WAYNE IIChief Financial Officer | Grant | 11.9k | $42.14 | $500k | Jul 1, 2026 |
| WILSON JOHN FOfficer and Director | Gift | 4.8k | — | — | Apr 30, 2026 |
| GAHLHOFF JERRY JRChief Executive Officer | Gift | 3.6k | — | — | Apr 29, 2026 |
| JONES DALE EDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| DONAHUE PAUL DDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| ROLLINS PAMELA RDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| ROLLINS TIMOTHY CURTISDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| MORRISON GREGORY B.Director | Grant | 2.7k | — | — | Apr 28, 2026 |
| HARDIN PAUL RUSSELLDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| SAMS LOUISE S.Director | Grant | 2.7k | — | — | Apr 28, 2026 |
| BELL SUSAN RDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| GUNNING PATRICK J.Director | Grant | 2.7k | — | — | Apr 28, 2026 |
| CARSON DONALD PDirector | Grant | 2.7k | — | — | Apr 28, 2026 |
| CHANDLER ELIZABETH BGeneral Counsel | Sell | 14.2k | $59.36 | $843k | Feb 25, 2026 |
| CHANDLER ELIZABETH BGeneral Counsel | Grant | 12.2k | — | — | Feb 20, 2026 |
| WILSON JOHN FOfficer and Director | Grant | 12.2k | — | — | Feb 20, 2026 |
| KRAUSE KENNETH DChief Financial Officer | Grant | 29.3k | — | — | Feb 20, 2026 |
| GAHLHOFF JERRY JRChief Executive Officer | Grant | 75.0k | — | — | Feb 20, 2026 |
| HARKINS WILLIAM WAYNE IIOfficer | Grant | 6.1k | — | — | Feb 20, 2026 |
No analyst notes on ROL yet.
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 4 | 9 | 1 | 1 | Hold2.53 |
| 1 mo ago | 4 | 4 | 9 | 1 | 1 | Hold2.53 |
| 2 mo ago | 4 | 5 | 8 | 1 | 1 | Buy2.47 |
| 3 mo ago | 6 | 6 | 6 | 0 | 0 | Buy2.00 |